Abstract

Membrane-assisted amyloid formation is implicated in human diseases, and many of the aggregating species accelerate amyloid formation and induce cell death. While structures of membrane-associated intermediates would provide tremendous insights into the pathology and aid in the design of compounds to potentially treat the diseases, it has not been feasible to overcome the challenges posed by the cell membrane. Here we use NMR experimental constraints to solve the structure of a type-2 diabetes related human islet amyloid polypeptide intermediate stabilized in nanodiscs. ROSETTA and MD simulations resulted in a unique b-strand structure distinct from the conventional amyloid b-hairpin and revealed that the nucleating NFGAIL region remains flexible and accessible within this isolated intermediate, suggesting a mechanism by which membrane-associated aggregation may be propagated. The ability of nanodiscs to trap amyloid intermediates as demonstrated could become one of the most powerful approaches to dissect the complicated misfolding pathways of protein aggregation.

Article and author information

Author details

  1. Diana C Rodriguez Camargo

    Institute for Advanced Study, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3522-4859
  2. Kyle J Korshavn

    Program in Biophysics, University of Michigan, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Alexander Jussupow

    Institute for Advanced Study, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Kolio Raltchev

    Center for Integrated Protein Science Munich, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. David Goricanec

    Center for Integrated Protein Science Munich, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Markus Fleisch

    Helmholtz Zentrum München, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Riddhiman Sarkar

    Center for Integrated Protein Science Munich, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Kai Xue

    Helmholtz Zentrum München, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Michaela Aichler

    Helmholtz Zentrum München, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Gabriele Mettenleiter

    Helmholtz Zentrum München, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Axel Karl Walch

    Helmholtz Zentrum München, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Carlo Camilloni

    Institute for Advanced Study, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9923-8590
  13. Franz Hagn

    Institute for Advanced Study, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Bernd Reif

    Center for Integrated Protein Science Munich, Technische Universität München, Garching, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Ayyalusamy Ramamoorthy

    Institute for Advanced Study, Technische Universität München, Garching, Germany
    For correspondence
    ramamoor@umich.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1964-1900

Funding

National Institutes of Health (AG048934)

  • Ayyalusamy Ramamoorthy

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Rodriguez Camargo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,867
    views
  • 596
    downloads
  • 67
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Diana C Rodriguez Camargo
  2. Kyle J Korshavn
  3. Alexander Jussupow
  4. Kolio Raltchev
  5. David Goricanec
  6. Markus Fleisch
  7. Riddhiman Sarkar
  8. Kai Xue
  9. Michaela Aichler
  10. Gabriele Mettenleiter
  11. Axel Karl Walch
  12. Carlo Camilloni
  13. Franz Hagn
  14. Bernd Reif
  15. Ayyalusamy Ramamoorthy
(2017)
Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate
eLife 6:e31226.
https://doi.org/10.7554/eLife.31226

Share this article

https://doi.org/10.7554/eLife.31226

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Ting-Wen Chen, Hsiao-Wei Liao ... Chung-Te Chang
    Research Article

    The mRNA 5'-cap structure removal by the decapping enzyme DCP2 is a critical step in gene regulation. While DCP2 is the catalytic subunit in the decapping complex, its activity is strongly enhanced by multiple factors, particularly DCP1, which is the major activator in yeast. However, the precise role of DCP1 in metazoans has yet to be fully elucidated. Moreover, in humans, the specific biological functions of the two DCP1 paralogs, DCP1a and DCP1b, remain largely unknown. To investigate the role of human DCP1, we generated cell lines that were deficient in DCP1a, DCP1b, or both to evaluate the importance of DCP1 in the decapping machinery. Our results highlight the importance of human DCP1 in decapping process and show that the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. Transcriptome and metabolome analyses outline the distinct functions of DCP1a and DCP1b in human cells, regulating specific endogenous mRNA targets and biological processes. Overall, our findings provide insights into the molecular mechanism of human DCP1 in mRNA decapping and shed light on the distinct functions of its paralogs.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Julia Shangguan, Ronald S Rock
    Research Article

    Myosin 10 (Myo10) is a motor protein known for its role in filopodia formation. Although Myo10-driven filopodial dynamics have been characterized, there is no information about the absolute number of Myo10 molecules during the filopodial lifecycle. To better understand molecular stoichiometries and packing restraints in filopodia, we measured Myo10 abundance in these structures. We combined SDS-PAGE densitometry with epifluorescence microscopy to quantitate HaloTag-labeled Myo10 in U2OS cells. About 6% of total intracellular Myo10 localizes to filopodia, where it enriches at opposite cellular ends. Hundreds of Myo10s are in a typical filopodium, and their distribution across filopodia is log-normal. Some filopodial tips even contain more Myo10 than accessible binding sites on the actin filament bundle. Live-cell movies reveal a dense cluster of over a hundred Myo10 molecules that initiates filopodial elongation. Hundreds of Myo10 molecules continue to accumulate during filopodial growth, but accumulation ceases when retraction begins. Rates of filopodial elongation, second-phase elongation, and retraction are inversely related to Myo10 quantities. Our estimates of Myo10 molecules in filopodia provide insight into the physics of packing Myo10, its cargo, and other filopodia-associated proteins in narrow membrane compartments. Our protocol provides a framework for future work analyzing Myo10 abundance and distribution upon perturbation.